Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (401-410 of 556) with videos related to

Pageof 56
Sort By:
Annals of Hepatology|May 24, 2020
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patientsKanako Kikukawa, Sawako Uchida-Kobayashi, Akihiro Tamori, et al.
Hepatology Communications|April 28, 2022
Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLDYoshihiro Kamada, Takashi Nakahara, Kensuke Munekage, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2010
Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapyMasaru Enomoto, Mami Mori, Tomohiro Ogawa, et al.
International Journal of Cancer|March 12, 2014
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancerKousaku Mimura, Takahiro Kamiya, Kensuke Shiraishi, et al.
Gastro Hep Advances|November 13, 2024
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver DiseaseMiwa Kawanaka, Yoshihiro Kamada, Hirokazu Takahashi, et al.
Pancreas|September 21, 2017
Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic JuiceShinichi Takano, Mitsuharu Fukasawa, Makoto Kadokura, et al.
Journal of Diabetes Investigation|May 21, 2014
Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver diseaseAkinobu Nakamura, Masato Yoneda, Yoshio Sumida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 13, 2010
Relapse of hepatitis C in a pegylated-interferon-alpha-2b plus ribavirin-treated sustained virological responderHideki Fujii, Yoshito Itoh, Naoki Ohnishi, et al.
International Immunology|June 7, 2011
HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in miceHideki Fujii, Manabu Ato, Yoshimasa Takahashi, et al.
Journal of Gastroenterology and Hepatology|January 3, 2019
HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver diseaseHideki Fujii, Kento Imajo, Masato Yoneda, et al.
Pageof 56

Showing results (401-410 of 556) with videos related to

Sort By:
Pageof 56
Annals of Hepatology|May 24, 2020
Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patientsKanako Kikukawa, Sawako Uchida-Kobayashi, Akihiro Tamori, et al.
Hepatology Communications|April 28, 2022
Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLDYoshihiro Kamada, Takashi Nakahara, Kensuke Munekage, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2010
Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: Regression of liver stiffness during entecavir therapyMasaru Enomoto, Mami Mori, Tomohiro Ogawa, et al.
International Journal of Cancer|March 12, 2014
Therapeutic potential of highly cytotoxic natural killer cells for gastric cancerKousaku Mimura, Takahiro Kamiya, Kensuke Shiraishi, et al.
Gastro Hep Advances|November 13, 2024
Serum Cytokeratin 18 Fragment Is an Indicator for Treating Metabolic Dysfunction-Associated Steatotic Liver DiseaseMiwa Kawanaka, Yoshihiro Kamada, Hirokazu Takahashi, et al.
Pancreas|September 21, 2017
Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic JuiceShinichi Takano, Mitsuharu Fukasawa, Makoto Kadokura, et al.
Journal of Diabetes Investigation|May 21, 2014
Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver diseaseAkinobu Nakamura, Masato Yoneda, Yoshio Sumida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 13, 2010
Relapse of hepatitis C in a pegylated-interferon-alpha-2b plus ribavirin-treated sustained virological responderHideki Fujii, Yoshito Itoh, Naoki Ohnishi, et al.
International Immunology|June 7, 2011
HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in miceHideki Fujii, Manabu Ato, Yoshimasa Takahashi, et al.
Journal of Gastroenterology and Hepatology|January 3, 2019
HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver diseaseHideki Fujii, Kento Imajo, Masato Yoneda, et al.
Pageof 56